Frequency of severe infections and correlation with immune markers in patients with neuromyelitis optica spectrum disorders treated with rituximab: a Swedish cohort study

被引:0
|
作者
Carlsson, Olof [1 ,2 ]
Jonsson, Dagur Ingi [1 ,3 ]
Brundin, Lou [1 ,2 ]
Iacobaeus, Ellen [1 ,2 ]
机构
[1] Karolinska Inst, Dept Clin Neurosci, Stockholm, Sweden
[2] Karolinska Univ Hosp, Dept Neurol, Stockholm, Sweden
[3] Karolinska Univ Hosp, Dept Neurophysiol, Stockholm, Sweden
关键词
D O I
暂无
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P722/1414
引用
下载
收藏
页码:622 / 623
页数:2
相关论文
共 50 条
  • [11] Pregnancy outcome in patients with neuromyelitis optica spectrum disorder treated with rituximab: A case-series study
    Ahadi, Maral Seyed
    Sahraian, Mohammad Ali
    Shaygannejad, Vahid
    Anjidani, Nassim
    Nejad, Seyed Ehsan Mohammadiani
    Moghadam, Nahid Beladi
    Ayromlou, Hormoz
    Pour, Gholam Ali Yousefi
    Yazdanbakhsh, Sepideh
    Jafari, Mehrdad
    Moghadasi, Abdorreza Naser
    CASPIAN JOURNAL OF INTERNAL MEDICINE, 2021, 12 : S491 - S494
  • [12] Effective Rituximab Treatment in Patients with Neuromyelitis Optica Spectrum Disorders Compared with Azathioprine and Mycophenolate
    Yang Yang
    Lifeng Chen
    Lei Wu
    Jiarui Yao
    Na Wang
    Xiaoqing Su
    Dongmei Li
    Lina Han
    Weiping Wu
    Dehui Huang
    Tianyu Jiang
    Zhenfu Wang
    Neurology and Therapy, 2022, 11 : 137 - 149
  • [13] real-world efficacy data of rituximab in patients with neuromyelitis optica spectrum disorders
    Coutinho Thomas, Domingo
    Martinez Lopez, Yazmin
    Alcocer Villanueva, Homero
    Gonzalez Gonzalez, Jose
    Rivera Lopez, Sarai
    Corona Vazquez, Teresita
    Rivas, Veronica
    Flores Rivera, Jose
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 1100 - 1100
  • [14] Survival in patients with neuromyelitis optica spectrum disorders: data from the Belgrade cohort
    Basuroski, I. Dujmovic
    Martinovic, V.
    Maric, G.
    Mesaros, S.
    Pekmezovic, T.
    Weinshenker, B.
    Drulovic, J.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 437 - 438
  • [15] Neuromyelitis optica spectrum disorders in an argentinian cohort: a hospital-based study
    Villa, A.
    Manin, A.
    Seimandi, C.
    Filkenstein, A. M.
    Tenembaum, S.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 750 - 750
  • [16] Frequency of sleep abnormalities in a Brazilian cohort of patients with neuromyelitis optica spectrum disorder
    Perin, M. M. M.
    Bichuetti, D. B.
    Souza, N. A.
    Oliveira, E. M. L.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 755 - 756
  • [17] Neuromyelitis optica spectrum disorders: long-term safety and efficacy of rituximab in caucasian patients
    Radaelli, M.
    Sangalli, F.
    Moiola, L.
    Rodegher, M.
    Colombo, B.
    Esposito, F.
    Fazio, R.
    Martinelli, V.
    Comi, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 : 351 - 351
  • [18] Neuromyelitis optica spectrum disorders: long-term safety and efficacy of rituximab in Caucasian patients
    Radaelli, M.
    Moiola, L.
    Sangalli, F.
    Esposito, F.
    Barcella, V.
    Ferre, L.
    Rodegher, M.
    Colombo, B.
    Fazio, R.
    Martinelli, V.
    Comi, G.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 (04) : 511 - 519
  • [19] Neuromyelitis Optica Spectrum Disorders in Argentinian patients: A hospital based study
    Pita, C.
    Fernandez, V.
    Garino, E.
    Melamud, L.
    Villa, A.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 412 - 412
  • [20] Aquaporin-4 antibody seroreversion in patients with neuromyelitis optica spectrum disorder treated with rituximab
    Rammohan, K.
    Tornes, L.
    Delgado, S.
    Garg, N.
    Dixon, C.
    Ortega, M.
    Hernandez, J.
    Hughes, N.
    Botero, M.
    Mccarthy, M.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 444 - 445